News
SurvivorNet on MSN4d
An Exciting Option For Difficult-To-Treat HER2+ Gastric Cancer: What New Data Means For PatientsFor the first time, a medicine aimed directly at the HER2 protein improved overall survival after gastric cancer progressed ...
Sportschosun on MSN5d
Helicobacter infection 2 to 3 times more likely to have stomach cancer...It's the second most common...This is the second highest number after thyroid cancer.Gastric cancer refers to a malignant tumor in the stomach, mainly ...
A clinical trial using engineered immune cells to hunt cancer cells has reported impressive results for solid tumours, a type ...
Phase 3 trial shows trastuzumab deruxtecan extends survival by over three months in advanced HER2-positive gastric cancer and ...
AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to results from a phase 3 study. | AstraZeneca’s Imfinzi has proven it can help ...
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE: AZN) have released detailed Phase III results that could help position their ...
AstraZeneca and Daiichi Sankyo’s drug extended survival by 30% compared to a widely used regimen, further establishing its ...
China NMPA approves Akeso's PD-1/CTLA-4 bispecific antibody cadonilimab for first-line treatment of cervical cancer: Hong Kong Friday, June 6, 2025, 12:00 Hrs [IST] Akeso, Inc., a ...
Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...
HCG Manavata Cancer Centre has successfully performed its first Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback